CN1562145A - 广升麻提取物、其制备方法及其用途 - Google Patents
广升麻提取物、其制备方法及其用途 Download PDFInfo
- Publication number
- CN1562145A CN1562145A CN 200410014710 CN200410014710A CN1562145A CN 1562145 A CN1562145 A CN 1562145A CN 200410014710 CN200410014710 CN 200410014710 CN 200410014710 A CN200410014710 A CN 200410014710A CN 1562145 A CN1562145 A CN 1562145A
- Authority
- CN
- China
- Prior art keywords
- extract
- radix serratulae
- serratulae chinensis
- group
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 11
- 239000000284 extract Substances 0.000 title claims description 47
- 244000025254 Cannabis sativa Species 0.000 title 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 title 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 title 1
- 235000009120 camo Nutrition 0.000 title 1
- 235000005607 chanvre indien Nutrition 0.000 title 1
- 239000011487 hemp Substances 0.000 title 1
- 239000003814 drug Substances 0.000 claims abstract description 13
- 208000026106 cerebrovascular disease Diseases 0.000 claims abstract description 11
- 208000002381 Brain Hypoxia Diseases 0.000 claims abstract description 5
- 208000009973 brain hypoxia - ischemia Diseases 0.000 claims abstract 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 239000000287 crude extract Substances 0.000 claims description 19
- 238000002360 preparation method Methods 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 9
- 238000000605 extraction Methods 0.000 claims description 9
- 238000010992 reflux Methods 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 239000003960 organic solvent Substances 0.000 claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 claims description 2
- 235000011941 Tilia x europaea Nutrition 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims description 2
- -1 filters Substances 0.000 claims description 2
- 239000004571 lime Substances 0.000 claims description 2
- 241000206501 Actaea <angiosperm> Species 0.000 abstract description 2
- 238000007670 refining Methods 0.000 description 30
- 241000700159 Rattus Species 0.000 description 26
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 20
- 210000004556 brain Anatomy 0.000 description 19
- 206010008118 cerebral infarction Diseases 0.000 description 13
- 201000006474 Brain Ischemia Diseases 0.000 description 11
- HXWZQRICWSADMH-SEHXZECUSA-N 20-hydroxyecdysone Natural products CC(C)(C)CC[C@@H](O)[C@@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C HXWZQRICWSADMH-SEHXZECUSA-N 0.000 description 10
- DCEFCUHVANGEOE-UHFFFAOYSA-N Ecdysterone Natural products CC(CC(C)(C)O)C(O)C(C)(O)C1CCC2(O)C3=CC(=O)C4CC(O)C(O)CC4(C)C3CCC12C DCEFCUHVANGEOE-UHFFFAOYSA-N 0.000 description 10
- NKDFYOWSKOHCCO-UHFFFAOYSA-N beta-ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(C)(O)C)CCC33O)C)C3=CC(=O)C21 NKDFYOWSKOHCCO-UHFFFAOYSA-N 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 206010008120 Cerebral ischaemia Diseases 0.000 description 7
- 230000001154 acute effect Effects 0.000 description 7
- 210000000269 carotid artery external Anatomy 0.000 description 7
- 230000002490 cerebral effect Effects 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- UIAGMCDKSXEBJQ-IBGZPJMESA-N 3-o-(2-methoxyethyl) 5-o-propan-2-yl (4s)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)[C@H]1C1=CC=CC([N+]([O-])=O)=C1 UIAGMCDKSXEBJQ-IBGZPJMESA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 6
- 239000004677 Nylon Substances 0.000 description 5
- 210000004004 carotid artery internal Anatomy 0.000 description 5
- 229920001778 nylon Polymers 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 206010020649 Hyperkeratosis Diseases 0.000 description 3
- 206010061216 Infarction Diseases 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 230000006837 decompression Effects 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000007574 infarction Effects 0.000 description 3
- 208000028867 ischemia Diseases 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000003657 middle cerebral artery Anatomy 0.000 description 3
- 229960000715 nimodipine Drugs 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 235000010288 sodium nitrite Nutrition 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 210000001364 upper extremity Anatomy 0.000 description 3
- 206010008089 Cerebral artery occlusion Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 210000002551 anterior cerebral artery Anatomy 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000003810 ethyl acetate extraction Methods 0.000 description 2
- 210000003194 forelimb Anatomy 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 201000007309 middle cerebral artery infarction Diseases 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 210000003977 optic chiasm Anatomy 0.000 description 2
- 230000004413 optic chiasma Effects 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- WURBVZBTWMNKQT-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 description 1
- 206010000117 Abnormal behaviour Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 241000624191 Klaseopsis chinensis Species 0.000 description 1
- 241000557281 Leuzea centauroides Species 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241000630329 Scomberesox saurus saurus Species 0.000 description 1
- 241000238370 Sepia Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 240000004460 Tanacetum coccineum Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000001168 carotid artery common Anatomy 0.000 description 1
- 210000001638 cerebellum Anatomy 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000001095 motoneuron effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000956 olfactory bulb Anatomy 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- SBNFWQZLDJGRLK-UHFFFAOYSA-N phenothrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 SBNFWQZLDJGRLK-UHFFFAOYSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 239000008354 sodium chloride injection Substances 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000001186 vagus nerve Anatomy 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410014710 CN1246000C (zh) | 2004-04-21 | 2004-04-21 | 广升麻提取物、其制备方法及其用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410014710 CN1246000C (zh) | 2004-04-21 | 2004-04-21 | 广升麻提取物、其制备方法及其用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1562145A true CN1562145A (zh) | 2005-01-12 |
CN1246000C CN1246000C (zh) | 2006-03-22 |
Family
ID=34478543
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200410014710 Expired - Lifetime CN1246000C (zh) | 2004-04-21 | 2004-04-21 | 广升麻提取物、其制备方法及其用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1246000C (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102232981A (zh) * | 2010-04-29 | 2011-11-09 | 秦引林 | 一种广升麻总甾酮的含量测定方法 |
CN102846734A (zh) * | 2011-06-30 | 2013-01-02 | 秦引林 | 广升麻提取物在制备治疗心血管疾病药物中的应用 |
CN103027967A (zh) * | 2011-09-30 | 2013-04-10 | 秦引林 | 一种广升麻提取物的制备方法 |
CN104069195A (zh) * | 2013-03-28 | 2014-10-01 | 江苏柯菲平医药有限公司 | 一种广升麻提取物注射剂及其制备方法 |
-
2004
- 2004-04-21 CN CN 200410014710 patent/CN1246000C/zh not_active Expired - Lifetime
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102232981A (zh) * | 2010-04-29 | 2011-11-09 | 秦引林 | 一种广升麻总甾酮的含量测定方法 |
CN102846734A (zh) * | 2011-06-30 | 2013-01-02 | 秦引林 | 广升麻提取物在制备治疗心血管疾病药物中的应用 |
CN103027967A (zh) * | 2011-09-30 | 2013-04-10 | 秦引林 | 一种广升麻提取物的制备方法 |
CN103027967B (zh) * | 2011-09-30 | 2015-01-07 | 秦引林 | 一种广升麻提取物的制备方法 |
CN104069195A (zh) * | 2013-03-28 | 2014-10-01 | 江苏柯菲平医药有限公司 | 一种广升麻提取物注射剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1246000C (zh) | 2006-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1857618A (zh) | 一种降糖中药制剂 | |
CN100342889C (zh) | 一种治疗痛风的中药制剂及其制备方法和应用 | |
CN1840166A (zh) | 温胆汤现代中药口服制剂及其生产方法 | |
CN1907316A (zh) | 一种预防和治疗骨科疾病的药物组合物 | |
CN1299702C (zh) | 一种骨科药物制剂的制备及其应用 | |
CN1742775A (zh) | 一种预防和治疗骨科疾病的药物组合物 | |
CN1246000C (zh) | 广升麻提取物、其制备方法及其用途 | |
CN1927279A (zh) | 一种用于皮肤病的中药组合物 | |
CN1709288A (zh) | 一种药物组合物及其制备方法和用途 | |
CN1634479A (zh) | 一种治疗感冒及上呼吸道感染的药物组合物、其制备方法及其用途 | |
CN1179726C (zh) | 柚皮苷在制备支持性治疗非典型性肺炎药物中的应用 | |
CN100551410C (zh) | 一种抗抑郁药物及制备方法 | |
CN1879701A (zh) | 一种治疗感冒的药物及其制备方法 | |
CN1181880C (zh) | 一种治疗慢性阻塞性肺病的复方薤白制剂及其制备方法 | |
CN1406585A (zh) | 一种治疗病毒性心肌炎的药物组合物 | |
CN1263490C (zh) | 一种助阳药及其制备方法 | |
CN1446554A (zh) | 治疗急、慢性胆囊炎的药物及其制备方法 | |
CN1895322A (zh) | 一种金感敏泡腾片及其制备方法 | |
CN1742798A (zh) | 五海瘿瘤制剂及新的制备方法 | |
CN1304043C (zh) | 龙鹤丹颗粒剂及其制备方法 | |
CN1543968A (zh) | 用桑白皮提取物制备的药物制剂 | |
CN1457809A (zh) | 一种蒲公英制剂及制备方法 | |
CN1308017C (zh) | 一种治疗泻泄、痢疾和痧气的药物组合物 | |
CN1709329A (zh) | 一种治疗女性痛经的组合物及制备方法 | |
CN101053624A (zh) | 一种治疗前列腺增生、慢性前列腺炎的中药及其制备工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20090731 Address after: Nanjing City, Jiangsu Province, behind our Tianfu garden 19 room 602 zip code: 210009 Co-patentee after: Qin Yinlin Patentee after: Huang Chi Address before: Nanjing City, Jiangsu Province, behind our Tianfu garden 19 room 602 zip code: 210009 Patentee before: Huang Chi |
|
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: JIANGSU CAREFREE PHARMACEUTICAL Co.,Ltd. Assignor: Qin Yinlin|Huang Chi Contract record no.: 2012320000161 Denomination of invention: Guangsheng hemp extract, its preparing method and use Granted publication date: 20060322 License type: Exclusive License Open date: 20050112 Record date: 20120305 |
|
ASS | Succession or assignment of patent right |
Owner name: JIANGSU CAREFREE PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: QIN YINLIN Effective date: 20121030 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20121030 Address after: Nanjing City, Jiangsu Province, the 210009 division behind Tianfu Park No. 19 room 602 Patentee after: Huang Chi Patentee after: JIANGSU CAREFREE PHARMACEUTICAL Co.,Ltd. Address before: Nanjing City, Jiangsu Province, the 210009 division behind Tianfu Park No. 19 room 602 Patentee before: Huang Chi Patentee before: Qin Yinlin |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: Nanjing City, Jiangsu Province, the 210009 division behind Tianfu Park No. 19 room 602 Patentee after: Huang Chi Patentee after: JIANGSU CAREPHAR PHARMACEUTICAL Co.,Ltd. Address before: Nanjing City, Jiangsu Province, the 210009 division behind Tianfu Park No. 19 room 602 Patentee before: Huang Chi Patentee before: JIANGSU CAREFREE PHARMACEUTICAL Co.,Ltd. |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20060322 |